Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Cambron-Mellott
Clinical Outcomes Associated With the Treatment of Newly Diagnosed Stage Iv Classical Hodgkin Lymphoma in Practice Settings in France, Germany and the United Kingdom
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Prognostic Significance of Tryptophan Catabolism in Newly Diagnosed Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Anticoagulation Treatment With VKA in France, Italy, Germany, Spain and United Kingdom. Results From the React AF Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Epidemiology, Diagnosis, and Treatment of HIV-Associated Non-Hodgkin Lymphoma in Resource-Limited Settings
Advances in Hematology
Hematology
Rituximab Plus ABVD in Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma
British Journal of Haematology
Hematology
Nivolumab Plus Doxorubicin, Vinblastine and Dacarbazine for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma: Checkmate 205 Cohort D 2-Year Follow-Up
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Clinical Characteristics and Treatment Outcomes of Pediatric Patients With Non-Hodgkin Lymphoma in East Asia
Cancer Research and Treatment
Cancer Research
Oncology
Physicians’ Preferences for Bone Metastases Treatments in France, Germany and the United Kingdom
BMC Health Services Research
Health Policy
Prognostic Value of Immunohistochemical Markers in Stage Iii/Iv Classical Hodgkin Lymphoma Treated Frontline in the Lysa Eortc 20012 Randomized Protocol
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Novel Treatment Strategies for Patients With Relapsed Classical Hodgkin Lymphoma
Blood Reviews
Oncology
Hematology
